Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease

Researchers identified Janus kinase inhibitors as a promising treatment for the severe drug-induced skin condition toxic epidermal necrolysis, by analyzing patient biopsies with deep visual proteomics.

Tonix acquires Upsher-Smith’s migraine products

Zembrace SymTouch 3mg and Tosymra 10mg are intended to treat adults with acute migraine. Credit: Towfiqu barbhuiya on Unsplash. Tonix Pharmaceuticals and Tonix Medicines have acquired

July 4, 2023

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

January 23, 2024

Researchers profile new drug combinations to fight antibiotic-resistant bacteria

Antimicrobial resistance – occurring when pathogens can survive antibiotic treatment – is one of the most rapidly emerging global public health threats today.

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.